Introduction
Clinical use of xylazine, an alpha-2-adrenergic agonist, has been a long standing practice throughout the word. Most striking reasons for the use of xylazine include its safe sedative efficacy, easy availability and economical price [5] .Alpha-2-adrenergic agonists are also used in combination with ketamine at reduced doses as compared to their individual doses to induce a good quality general anesthesia and to avoid emergence of various side effects associated with individual use of xylazine and ketamine [22] .It has been observed thatblood profilechanges which occur, during and after the surgical procedures, critically affect the surgical outcomes [1] .One of these changes is raiseinhaemoglycemic level after anaesthesia administration. There are various factors that can disturb blood glucose level during the surgery and effect of sedatives is very important among these factors [2] . Adrenaline and nor adrenaline maintain normal glucose level in body which effects both production as well as disposal of glucose throughout the body [3] . Surgical stress is often accompanied by hormonal and metabolic changes (catabolism of stored fats), and the proportion of these changes depends on the extent of procedure and existing disorder [4] . Xylazine is commonly used in veterinary field for different purposes, most commonly as sedative, analgesic and muscle relaxant.
Studies on the effect of alpha-2-adrenergic agonists have proved that these agents cause decrease in plasma catecholamine concentrations that resultantly inhibit insulin release and ultimately lead to increased plasma glucose level [6] . Ketamine increases the blood glucose level in cats undergoing surgery as compared to the cats having no surgical stress [7] . Anesthetic agents along with the surgical procedures can increase the blood glucose level and can disturb the surgical outcomes [8] . Diazepam belongs to the benzodiazepine group. It is a potent tranquilizer that is used alone as well as in combination with other agents. Haemoglycemic effects of diazepam are not fully known. Present study was designed to see the long term haemoglycemic effect of xylazine, diazepam and ketamine in surgically treated dogs.
II. Materials And Methods
This clinical study was conducted on 30 adult dogs of either sex undergoing different minor surgical procedures (wound closure, abscess drainage, hematoma correction, fracture reduction, cast application and dental extraction) at outdoor clinic of Pet Centre, University of Veterinary and Animal Sciences, Lahore, Pakistan. All dogs were divided into three groups titled A, B and C; each group with 10 dogs. Complete physical examination was carried out for each dog to determine the general health status prior to anaesthesia administration and surgical procedure. All dogs were kept off feed 12 hours prior to the drug administration. In group A, dogs were treated with xylazine (1.1mg/kg i.v), in group B, dogs were treated with diazepam (0.5 mg/kg, i.v) while dogs in group C were treated with ketamine (10 mg/kg, i.v).
Sample collection and handling
Each dog was implanted with venous cannula in cephalic vein for blood sample collection.1 mL blood sample was collected for each test. First sample was collected prior to the drug administration to determine baseline reference value of serum glucose level. After drug administration sampling was carried out at different time intervals during and after the surgical procedure. Sampling intervals were: 0 minute, 30 minutes, 1 hr, 2 hrs, 4 hrs, 6 hrs, and 8 hrs [2] . Each blood sample was immediately shifted to the gel clot activator vacutainer followed by serum separation. Serum was then shifted to the eppendorf tube using micropipette. Samples were then processed at Pet Centre Diagnostic Laboratory, University of Veterinary and Animal Sciences, Lahore, Pakistan, for analysis of serum glucose levels.
Statistical analysis
Data were statistically analyzed using one way analysis of variance (ANOVA) for repeated measures and confidence interval was selected as 95%. P value <0.05 was considered significant.
III. Results
Mean haemoglycemic values of Group A at different intervals, are presented in 
IV. Discussion
This study was designed to evaluate the long term individual effects of xylazine and diazepam as sedatives and ketamine anesthetic in clinical cases of dogs undergoing minor surgical procedures. It has been observed that when haemoglycemic level is raised beyond the normal values it affects the immune system by disturbing the process of pathogens killing, phagocytosis, antibodies (immunoglobulin) glycosylation and decrease in neutrophils [9] . Because of increased protein catabolism prognosis of skin grafting is often affected by high haemoglycemic level [10] . In this under discussion study it was observed that the use of ketamine along with surgical stress elevates the haemoglycemic values [8] . Stress activates hypothalamus which in turn stimulates the release of adrenergic hormones [1] and activates the sympathetic nervous system part of autonomic nervous system. Release of adrenergic hormones activates adrenal glands (medullary portion) and epinephrine is released [11] which in turn activates the process of glycogenolysis in muscles as well as in liver [1] . Stress also activates the corticotropic releasing hormone (CRH) following the stimulation of hypothalamus. This hormone then stimulates ACTH and affects adrenal gland which then releases cortisol. Cortisol causesglycogenolysis in muscles as well as in liver [1] . Findings of the present study are in line with the earlier reported studies. Current study revealed the same hyperglycemic effects of intravenously administered ketamine. This increase in haemoglycemic level due to ketamine could be either due to the stress or suppression of insulin hormone or might be due to the elevated concentration of cortisol [12] . Ketamine has similar haemoglycemic effect as that of alpha-2-adrenoceptor agonist drugs i.e. xylazine, detomidine and medetomidine [12] . A recent study on ketamine showed that haemoglycemic effect of the dissociative anesthetic depends on the dosage of the agent [13] .
It has been observed in various studies that alpha-2-adrenoreceptor agonist xylazine increases the haemoglycemic level in cattle [18] as well as in rats [15] depending upon its dosage. It has been reported on the basis of previous studies that when xylazine is administered at a dosage of 2.2 mg/kg, intramuscularly, haemoglycemic level increases and insulin concentration decreases [14] . Findings of the present study have confirmed that xylazine alone elevates the haemoglycemic level when administered at a dosage of 1.1 mg/Kg, intravenously (P<0.05) as compared to the normal baseline values. This increase was due to the reduced secretion of insulin hormone. [19] has documented the same findings in feline while [18] also documented the same results in ovine. Besides insulin there are also some other hormones like glucagon which may affect the haemoglycemic level. Alpha-2-adrenoreceptor agonist xylazine elevates the concentration of these hormones in blood [20] . It is also documented earlier that xylazine and ketamine cocktail elevates haemoglycemic levelssignificantly in canine, ovine as well as in deer [16, 17] . Earlier studies showed that diazepam alone increases the haemoglycemic levels in animals. Same findings are also documented in this study as elevated haemoglycemic level with the use of diazepam as 0.5 mg/kg when administered intravenously. Increase in haemoglycemic values occurred as a result of stimulation of adrenoreceptors ultimately leading to reduced insulin secretion, stress hormones may also be one of the contributing factors [21] .
V. Conclusion
On the basis of findings of the present study it is concluded that intravenous use of xylazine, diazepam sedatives and ketamine anestheticelicit effect on haemoglycemic levels to a variable extent. It is recommended that a regular and continuous haemoglycemicmonitoring must be carried out at regular intervals throughout the preand post anesthetic period to rule out any possibility of unwanted and hazardous effects of hyperglycemia.
